Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

Corrie, P G; Marshall, A; Nathan, P D; Lorigan, P; Gore, M; Tahir, S; Faust, G; Kelly, C G; Marples, M; Danson, S J; Marshall, E; Houston, S J; Board, R E; Waterston, A M; Nobes, J P; Harries, M; Kumar, S; Goodman, A; Dalgleish, A; Martin-Clavijo, A; Westwell, S; Casasola, R; Chao, D; Maraveyas, A; Patel, P M; Ottensmeier, C H; Farrugia, D; Humphreys, A; Eccles, B; Young, G; Barker, E O; Harman, C; Weiss, M; Myers, K A; Chhabra, A; Rodwell, S H; Dunn, J A; Middleton, M R

Corrie, P G; Marshall, A; Nathan, P D; Lorigan, P; Gore, M; Tahir, S; Faust, G; Kelly, C G; Marples, M; Danson, S J; Marshall, E; Houston, S J; Board, R E; Waterston, A M; Nobes, J P; Harries, M; Kumar, S; Goodman, A; Dalgleish, A; Martin-Clavijo, A; Westwell, S; Casasola, R; Chao, D; Maraveyas, A; Patel, P M; Ottensmeier, C H; Farrugia, D; Humphreys, A; Eccles, B; Young, G; Barker, E O; Harman, C; Weiss, M; Myers, K A; Chhabra, A; Rodwell, S H; Dunn, J A; Middleton, M R.

Ann Oncol ; 30(12): 2013-2014, 2019 12 01.

Article in En | MEDLINE | ID: mdl-31430371

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google